MA53672A - Inhibiteurs de cdpk1, compositions et procédés associés - Google Patents
Inhibiteurs de cdpk1, compositions et procédés associésInfo
- Publication number
- MA53672A MA53672A MA053672A MA53672A MA53672A MA 53672 A MA53672 A MA 53672A MA 053672 A MA053672 A MA 053672A MA 53672 A MA53672 A MA 53672A MA 53672 A MA53672 A MA 53672A
- Authority
- MA
- Morocco
- Prior art keywords
- cdpk1
- inhibitors
- compositions
- methods therefor
- therefor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862733361P | 2018-09-19 | 2018-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53672A true MA53672A (fr) | 2021-07-28 |
Family
ID=69887825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053672A MA53672A (fr) | 2018-09-19 | 2019-09-19 | Inhibiteurs de cdpk1, compositions et procédés associés |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210347780A1 (fr) |
| EP (1) | EP3853230A4 (fr) |
| MA (1) | MA53672A (fr) |
| WO (1) | WO2020061279A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019036001A1 (fr) | 2017-08-17 | 2019-02-21 | Vyera Pharmaceuticals, LLC | Inhibiteur de cdpk1, compositions et procédés associés |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0820342A2 (pt) * | 2007-11-07 | 2015-05-26 | Foldrx Pharmaceuticals Inc | Modulação de tráfego de proteína |
| US8642606B2 (en) * | 2010-09-29 | 2014-02-04 | Plexxikon Inc. | ZAP-70 active compounds |
| WO2017161344A1 (fr) * | 2016-03-17 | 2017-09-21 | The Regants Of The University Of California | Compositions et méthodes pour traiter les parasitoses |
| TW201837040A (zh) * | 2017-03-15 | 2018-10-16 | 美商微拉製藥公司 | Cdpk1抑制劑及與其相關之組合物及方法 |
| WO2019036001A1 (fr) * | 2017-08-17 | 2019-02-21 | Vyera Pharmaceuticals, LLC | Inhibiteur de cdpk1, compositions et procédés associés |
-
2019
- 2019-09-19 EP EP19863891.8A patent/EP3853230A4/fr active Pending
- 2019-09-19 US US17/277,603 patent/US20210347780A1/en active Pending
- 2019-09-19 MA MA053672A patent/MA53672A/fr unknown
- 2019-09-19 WO PCT/US2019/051877 patent/WO2020061279A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3853230A1 (fr) | 2021-07-28 |
| WO2020061279A1 (fr) | 2020-03-26 |
| EP3853230A4 (fr) | 2022-07-06 |
| US20210347780A1 (en) | 2021-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA54875A (fr) | Compositions oligonucléotidiques et procédés associés | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| DK3612525T3 (da) | Pd-1-/pd-l1-inhibitorer | |
| DK3842442T3 (da) | Sammensætninger og fremgangsmåder til hæmning af arginaseaktivitet | |
| MA49858A (fr) | Composés, compositions et procédés | |
| DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| MA43380A (fr) | Récepteurs chimériques modifiés et compositions et procédés associés | |
| MA52413A (fr) | Inhibiteurs de cd73 | |
| DK3368541T3 (da) | Sammensætninger og metoder til inhibiering af arginaseaktivitet | |
| DK3386534T3 (da) | Sammensætninger og fremgangsmåder til internalisering af enzymer | |
| DK3247371T3 (da) | Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil | |
| MA52812A (fr) | Inhibiteurs de sarm1 | |
| IL276813A (en) | Arginase inhibitors | |
| DK3672976T3 (da) | Bcl-2-hæmmere | |
| MA54953A (fr) | Composés, compositions et procédés | |
| DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
| DK3681884T3 (da) | Rad51-inhibitorer | |
| MA54959A (fr) | Composés, compositions et procédés | |
| DK3774817T3 (da) | Bcl6-hæmmere | |
| MA55716A (fr) | Inhibiteurs de dihydroorotate déshydrogénase | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| MA54695A (fr) | Inhibiteurs de dihydroorotate déshydrogénase | |
| MA55909A (fr) | Inhibiteurs de cdk | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer |